{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-001119","form_type":"8-K","ticker":"PMCB","cik":"0001157075","company_name":"PharmaCyte Biotech, Inc.","filed_at":"2022-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.539051+00:00","generated_at":"2026-06-27T06:55:00.858017+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pharmacyte Biotech notifies Nasdaq of board independence non-compliance after director death","bullets":["Board member Thomas C.K. Yuen died Feb 13, 2022; company notified Nasdaq Feb 15, 2022.","Due to his death, majority of board no longer independent, violating Nasdaq Listing Rule 5605(b)(1).","Company has automatic cure period; expects to regain compliance by appointing new independent director."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-001119","json":"https://secwatch.observer/filing/0001683168-22-001119.json","markdown":"https://secwatch.observer/filing/0001683168-22-001119.md","text":"https://secwatch.observer/filing/0001683168-22-001119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157075/000168316822001119/0001683168-22-001119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157075/000168316822001119/pharmacyte_i8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T06:55:00.858017+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}